TriMas Corp

TRS remains in a Stage 2 advancing corrective reset with the higher-high, higher-low sequence intact above the 50 DMA. The active Support Failure pattern signals downside risk, but the 50 DMA has held as support. Short-term timing is unfavorable as price is capped by declining 9-EMA and 21-EMA, offering no clear entry. We will stalk for a pullback into the 50 DMA support zone and await acceptance before engaging in the medium-term bullish trade.

• ↑Q1 net sales rose 10% YoY to $168M, driven by 7.3% organic growth.
• ↑FY26 guidance calls for 3–6% sales growth and +300 bps margin expansion.
• ↓Q1 free cash flow was negative $16M, underscoring execution risk.